A drug with outstanding PD (it shuts down a cancer enzyme perfectly) but terrible PK (it is destroyed by stomach acid or cleared by the liver in 2 minutes) will never become a medicine. Pharmacology is the science of measuring, predicting, and optimizing this window.
Pharmacology, especially PK/PD modeling, is used throughout this process to interpret results, design subsequent trials, and ultimately to write the drug label. pharmacology in drug discovery and development
Phase 1 is a pure pharmacology study. It is not about efficacy; it is about safety and human PK/PD. A drug with outstanding PD (it shuts down
Before a drug can be tested in humans, it must prove it is safe enough to try. This is the domain of preclinical pharmacology. Phase 1 is a pure pharmacology study
In the early phases, pharmacology focus is on identifying and validating biological targets—such as enzymes, receptors, or cellular pathways—that are implicated in diseases.
This is where become sacred. A pharmacologist measures two critical things: